17.02.2012 • News • Ashland • over-the-counter drugs • pharmaceutical ingredients

Ashland Expands PVP Production

Ashland said it is responding to strong demand for Plasdone polyvinyl pyrrolidone (PVP) by adding new low-viscosity, pharmaceutical-grade PVP capacity at its manufacturing facility in Calvert City, Ky. The company said the new capacity will further strengthen its position in the market and will enable the company to continue supporting the growing needs of its pharmaceutical customers. The additional capacity is currently being validated for pharmaceutical-grade PVP production and will be available for sale to Ashland's pharmaceutical customers in March 2012.

 

 

Company

Logo:

Ashland

500 Hercules Road Building 8145
19808 Wilmington, DE
US

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Top-Feature

most read

Photo
28.07.2025 • News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.